Pubblicazioni

Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia

2018 - HAEMATOLOGICA

Fedullo, Al; Messina, M; Elia, L; Piciocchi, A; Gianfelici, V; Lauretti, A; Soddu, S; Puzzolo, Mc; Minotti, C; Ferrara, F; Martino, B; Chiusolo, P; Calafiore, V; Paolini, S; Vignetti, M; Vitale, A; Guarini, A; FoÃ , R; Chiaretti, S.

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study

2018 - HAEMATOLOGICA

Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; FoÃ , R

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells

2018 - HAEMATOLOGICA

Spagnuolo, Manuela; Regazzo, Giulia; De Dominici, Marco; Sacconi, Andrea; Pelosi, Andrea; Korita, Etleva; Marchesi, Francesco; Pisani, Francesco; Magenta, Alessandra; Lulli, Valentina; Cordone, Iole; Mengarelli, Andrea; Strano, Sabrina; Blandino, Giovanni; Rizzo, Maria G; Calabretta, Bruno

A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis.

2018 - HAEMATOLOGICA

Quattrocchi, Alberto; Tomassini, Simona; Billi, M.; Scerpa, Mc.; Cenfra, N.; Gentile, Martina; Maiorca, Carlo; Ceccherelli, A.; De Marinis, E.; Grignani, F.; Cimino, G.; Nervi, C.

TARGETING SIGLEC-7: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO POTENTIATE THE CYTOTOXIC FUNCTIONS OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA

2018 - HAEMATOLOGICA

Daly, J; Sarkar, S; Natoni, A; Hu, J; Chauhan, S; Henderson, R; Duggan, T; Mccarthy, Pl; Mcellistrim, C; O'Dwyer, M

Low dose cyclophosphamide potentiates the anti-myeloma activity of daratumumab through augmentation of macrophage-induced ADCP

2018 - HAEMATOLOGICA

S, Naicker; A, Rigalou; C, Mcellistrim; R, Henderson; Natoni, Alessandro; C, Chiu; K, Sasser; A, Ryan; M, O'Dwyer

Novel kinase inhibitors afuresertib and PIM447 are active alone and in combination with standard therapies, respectively, in a predictive MM in vivo model, and a CRISPR genome-wide screening approach identifies clinically-relevant biomarkers determining susceptibility to these therapeutic strategies

2018 - HAEMATOLOGICA

N, Keane; Natoni, Alessandro; M, Sharik; M, Chesi; Pl, Bergsagel; M, O'Dwyer

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, Erminia; Ferrara, G.; Malaspina, Francesco; Santoro, Rc; Pasca, S.; Castaman, G.; Peyvandi, F.; Foa, Roberto; Mazzucconi, Maria Gabriella

VALIDATION OF THE REVISED IPSET-THROMBOSIS SCORE IN 734 PATIENTS WITH WHO 2016-DEFINED ESSENTIAL THROMBOCYTHEMIA. REPORT OF THE REGISTRO ITALIANO TROMBOCITEMIE

2017 - HAEMATOLOGICA

Gugliotta, L; Iurlo, A; Gugliotta, G; Tieghi, A; Gaidano, G; Dragani, A; Scalzulli, P; Martinelli, V; Martino, B; Randi, Ml; Appolloni, V; Maschio, N; Langella, M; Santoro, Cristina; Rago, A; Cacciola, E; Cacciola, R; Caocci, G; Plebani, S; Santoro, U; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF A-HYPO-FIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, E; Ferrara, G; Ferretti, Antonietta; Santoro, Rc; Pasca, S; Castaman, G; Peyvandi, F; Foa, Roberto; Mazzucconi, Maria Gabriella

IS THE SURVIVAL OF PATIENTS WITH ESSENTIAL THROMBOCYTEMIA BETTER IN THE LAST DECADE? RETROSPECTIVE ANALYSIS OF DATABASE OF LATIAL GROUP FOR THE STUDY OF NMP, PH NEGATIVE

2017 - HAEMATOLOGICA

Montanaro, M; Andriani, A; Cedrone, M; Santoro, Cristina; Spirito, F; Crescenzi, Sl; Porrini, R; Di Veroli, A; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Cimino, Giuseppe; Mazzucconi, Maria Gabriella; Latagliata, R.

PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R)+/- R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS

2017 - HAEMATOLOGICA22nd Congress of the European-Hematology-Association

DI ROCCO, Alice; DE ANGELIS, Federico; Petrucci, L; Vozzella, F; De Benedittis, D; Foa, Roberto; Martelli, Maurizio

REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

2017 - HAEMATOLOGICAREGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

Martini, V; Molfetta, R; Severin, F; Trimarco, V; Frezzato, F; Raggi, F; Martinello, L; Visentin, A; Scomazzon, E; Facco, M; Semenzato, G; Paolini, R; Trentin, L.

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials

2017 - HAEMATOLOGICA

Eichenauer, Dennis A.; Becker, Ingrid; Monsef, Ina; Chadwick, Nicholas; De Sanctis, Vitaliana; Federico, Massimo; Fortpied, Catherine; Gianni, Alessandro M.; Henry-amar, Michel; Hoskin, Peter; Johnson, Peter; Luminari, Stefano; Bellei, Monica; Pulsoni, Alessandro; Sydes, Matthew R.; Valagussa, Pinuccia; Viviani, Simonetta; Engert, Andreas; Franklin, Jeremy

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.

2017 - HAEMATOLOGICA

Broccoli, Alessandro; Pellegrini, Cinzia; DI ROCCO, Alice; Puccini, Benedetta; Patti, Caterina; Gini, Guido; Mannina, Donato; Tani, Monica; Rusconi, Chiara; Romano, Alessandra; Vanazzi, Anna; Botto, Barbara; Carlo-Stella, Carmelo; Hohaus, Stefan; Musto, Pellegrino; Mazza, Patrizio; Molica, Stefano; Corradini, Paolo; Fama, Angelo; Gaudio, Francesco; Merli, Michele; Gravetti, Angela; Gritti, Giuseppe; Arcari, Annalisa; Tosi, Patrizia; Marina Liberati, Anna; Pinto, Antonello; Pavone, Vincenzo; Gherlinzoni, Filippo; Naso, Virginia; Volpetti, Stefano; Trentin, Livio; Cecilia Goldaniga, Maria; Bonfichi, Maurizio; De Renzo, Amalia; Schiavotto, Corrado; Spina, Michele; Storti, Sergio; Michele Carella, Angelo; Stefoni, Vittorio; Argnani, Lisa; Luigi Zinzani, Pier

Clinical relevance of silent red blood cell autoantibodies.

2017 - HAEMATOLOGICA

Mauro, Fr; Trastulli, F; Alessandri, C; Valesini, G; Giovannetti, G; Riemma, C; Porrazzo, M; Pepe, S; Colafigli, G; Caputo, Md; De Propris, Ms; Guarini, Ar; Girelli, G; Coluzzi, S; FoÃ , R

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification

2017 - HAEMATOLOGICA

Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Ciolli, Stefania; Mauro, Francesca Romana; Mannina, Donato; Del Poeta, Giovanni; DâArena, Giovanni; Massaia, Massimo; Coscia, Marta; Molica, Stefano; Pozzato, Gabriele; Efremov, Dimitar G.; Vannata, Barbara; Marasca, Roberto; Galieni, Pietro; Cuneo, Antonio; Orlando, Sonia; Piciocchi, Alfonso; Boncompagni, Riccardo; Vincelli, Donatella; Liberati, Anna Marina; Russo, Filomena; Foa, Robin

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia

2017 - HAEMATOLOGICA

Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Albano, Francesco; Iurlo, Alessandra; Intermesoli, Tamara; Abruzzese, Elisabetta; Levato, Luciano; DâAdda, Mariella; Pregno, Patrizia; Cavazzini, Francesco; Stagno, Fabio; Martino, Bruno; La Barba, Gaetano; SorÃ , Federica; Tiribelli, Mario; Bigazzi, Catia; Binotto, Gianni; Bonifacio, Massimiliano; Caracciolo, Clementina; Soverini, Simona; FoÃ , Robin; Cavo, Michele; Martinelli, Giovanni; Pane, Fabrizio; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio

EFFICACY, SAFETY AND COST ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP

2017 - HAEMATOLOGICA

DI ROCCO, Alice; Scerbo, Gaia; Ansuinelli, Michela; Petrucci, Luigi; LA ROCCA, Ursula; Coggi, Angela; Arduini, Enrica; Foa, Roberto; Martelli, Maurizio

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

2017 - HAEMATOLOGICA

Orsini, Sara; Noris, Patrizia; Bury, Loredana; Heller, Paula G.; Santoro, Cristina; Kadir, Rezan A.; Butta, Nora C.; Falcinelli, Emanuela; Cid, Ana Rosa; Fabris, Fabrizio; Fouassier, Marc; Miyazaki, Koji; Lozano, Maria Luisa; ZÃºÃ±iga, Pamela; Flaujac, Claire; Podda, Gian Marco; Bermejo, Nuria; Favier, Remi; Henskens, Yvonne; De Maistre, Emmanuel; De Candia, Erica; Mumford, Andrew D.; Ozdemir, Gul Nihal; Eker, Ibrahim; Nurden, Paquita; Bayart, Sophie; Lambert, Michele P.; Bussel, James; Zieger, Barbara; Tosetto, Alberto; Melazzini, Federica; Glembotsky, Ana C.; Pecci, Alessandro; Cattaneo, Marco; Schlegel, Nicole; Gresele, Paolo

Advances in diagnosis of hereditary hemolytic anemias: thermogravimetry coupled with chemometrics

2017 - HAEMATOLOGICA

Risoluti, Roberta; Materazzi, Stefano; Sorrentino, Francesco; Maffei, L; Bozzi, C; Caprari, P

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

ESTABLISHING A NATIONAL NETWORK OF LABORATORIES USING NEXT GENERATION AMPLICON DEEP SEQUENCING FOR BCR-ABL1 KINASE DOMAIN MUTATION SCREENING: THE 'NEXT-IN-CML' STUDY

2017 - HAEMATOLOGICA

Soverini, S; De Benedittis, C; Bavaro, L; Martelli, M; Stella, S; Iurlo, A; Orofino, N; Barate, C; Galimberti, S; Sica, S; Sora, F; Rossi, Ar; Albano, F; Ciceri, F; Lunghi, F; Castagnetti, F; Gugliotta, G; Tenti, E; Rosti, G; Papayannidis, C; Stagno, F; Vigneri, P; Serra, A; Saglio, G; Carnuccio, F; Pane, F; Errichiello, S; Annunziata, M; Breccia, M; Abruzzese, E; Bonifacio, M; Novella, E; Di Bona, E; Sancetta, R; Calistri, E; Spinosa, G; D'Adda, M; Capodanno, I; Baccarani, M; Cavo, M; Martinelli, G

DEVELOPMENT AND EXTERNAL VALIDATION OF A NEW PATIENT-CENTERED PROGNOSTIC INDEX FOR PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES

2017 - HAEMATOLOGICA

Efficace, F; Cottone, F; Abel, G; Niscola, P; Gaidano, G; Bonnetain, F; Anota, A; Caocci, G; Cronin, A; Fianchi, L; Breccia, M; Stauder, R; Platzbecker, U; Palumbo, Ga; Luppi, M; Invernizzi, R; Bergamaschi, M; Borin, L; Di Tucci, Aa; Zhang, H; Sprangers, M; Vignetti, M; Mandelli, F

IMPACT OF COMORBIDITIES AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB

2017 - HAEMATOLOGICA

Palandri, F; Tiribelli, M; Bonifacio, M; Palumbo, Ga; Tieghi, A; Polverelli, N; Bergamaschi, M; Cavazzini, F; Isidori, A; Binotto, G; Cimino, G; D'Adda, M; Crugnola, M; Bosi, C; Sgherza, N; Spinsanti, M; Molica, M; Fama, A; Andriani, A; Cerqui, E; Lazzaro, A; Scaffidi, L; Massaro, F; Latagliata, R; Fanin, R; Russo, D; Aversa, F; Cuneo, A; Cavo, M; Vianelli, N; Breccia, M